Nevertheless, the upregulation of METTL3, YTHDF1, and HNRNPA2B1 and the downregulation of NUDT21 and FTO were found to be associated with an advancing disease status, as evidenced by both the cell line and PCa clinical data. This evidence concerns the gene NUDT21 and posterior cortical atrophy.